AAPL294.65+0.35 (+0.12%) ▲|ABBV235.29+0.53 (+0.22%) ▲|ABT90.62+0.09 (+0.10%) ▲|ACN130.29+3.28 (+2.58%) ▲|ADBE197.57+0.14 (+0.07%) ▲|AMAT576.53-9.36 (-1.60%) ▼|AMD513.45-6.40 (-1.23%) ▼|AMGN352.48+5.47 (+1.57%) ▲|AMT175.71-3.67 (-2.05%) ▼|AMZN235.54+1.43 (+0.61%) ▲|AVGO379.23-0.93 (-0.24%) ▼|AXP341.87+4.09 (+1.21%) ▲|BA219.37+2.66 (+1.23%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG182.88+13.94 (+8.25%) ▲|BLK979.37-35.97 (-3.54%) ▼|BMY55.15-0.39 (-0.69%) ▼|BNY143.76-3.53 (-2.40%) ▼|BRK-B495.50+2.69 (+0.54%) ▲|C144.05-0.93 (-0.64%) ▼|CAT986.09+1.85 (+0.19%) ▲|CL92.01+0.58 (+0.63%) ▲|CMCSA22.64-0.17 (-0.72%) ▼|COF200.08+2.27 (+1.15%) ▲|COP106.76-3.21 (-2.92%) ▼|COST960.39+2.71 (+0.28%) ▲|CRM153.20-0.23 (-0.15%) ▼|CSCO119.21-1.94 (-1.60%) ▼|CVS102.08+0.51 (+0.50%) ▲|CVX171.54-4.44 (-2.52%) ▼|DE604.97+13.03 (+2.20%) ▲|DHR188.38+9.41 (+5.26%) ▲|DIS101.29-2.24 (-2.16%) ▼|DUK126.03+0.98 (+0.78%) ▲|EMR141.03-2.11 (-1.47%) ▼|FDX315.83-1.42 (-0.45%) ▼|GD344.59-5.75 (-1.64%) ▼|GE364.03+7.56 (+2.12%) ▲|GEV1,047.61+12.63 (+1.22%) ▲|GILD125.67+0.62 (+0.49%) ▲|GM79.16+0.21 (+0.27%) ▲|GOOG344.09-1.99 (-0.58%) ▼|GOOGL344.92-1.17 (-0.34%) ▼|GS1,075.17-19.28 (-1.76%) ▼|HD340.59+16.14 (+4.97%) ▲|HON226.97+4.60 (+2.07%) ▲|IBM263.00-1.94 (-0.73%) ▼|INTC130.46-1.83 (-1.38%) ▼|INTU263.87+5.82 (+2.26%) ▲|ISRG402.54-0.64 (-0.16%) ▼|JNJ240.13+1.05 (+0.44%) ▲|JPM333.82-0.32 (-0.10%) ▼|KO80.75+0.44 (+0.54%) ▲|LIN515.95+3.69 (+0.72%) ▲|LLY1,111.82+4.74 (+0.43%) ▲|LMT493.31-10.36 (-2.06%) ▼|LOW220.86+7.32 (+3.43%) ▲|LRCX367.32-4.01 (-1.08%) ▼|MA494.63+6.56 (+1.34%) ▲|MCD274.48+2.82 (+1.04%) ▲|MDLZ61.90+0.84 (+1.37%) ▲|MDT80.37-0.27 (-0.33%) ▼|META557.65-4.55 (-0.81%) ▼|MMM165.83+3.99 (+2.47%) ▲|MO71.80+0.19 (+0.26%) ▲|MRK120.77+1.17 (+0.98%) ▲|MS220.38-5.66 (-2.50%) ▼|MSFT368.27-5.67 (-1.52%) ▼|MU1,027.39-24.38 (-2.32%) ▼|NEE87.28+0.85 (+0.98%) ▲|NFLX72.16-0.67 (-0.91%) ▼|NKE41.84-0.55 (-1.29%) ▼|NOW93.68-2.26 (-2.36%) ▼|NVDA197.58-2.42 (-1.21%) ▼|ORCL156.40-8.77 (-5.31%) ▼|PEP142.19+0.14 (+0.10%) ▲|PFE24.05-0.68 (-2.73%) ▼|PG152.31+1.45 (+0.96%) ▲|PLTR113.65-3.05 (-2.61%) ▼|PM178.10-0.59 (-0.33%) ▼|QCOM194.61-9.52 (-4.66%) ▼|RTX185.47-0.92 (-0.49%) ▼|SBUX104.00+2.95 (+2.92%) ▲|SCHW91.57-1.60 (-1.72%) ▼|SO95.48+0.55 (+0.57%) ▲|SPG220.91+4.17 (+1.92%) ▲|T22.38-0.43 (-1.88%) ▼|TMO490.69+21.34 (+4.55%) ▲|TMUS181.92-2.65 (-1.44%) ▼|TSLA375.74-5.87 (-1.54%) ▼|TXN303.66-0.70 (-0.23%) ▼|UBER74.20+4.53 (+6.50%) ▲|UNH405.93-3.32 (-0.81%) ▼|UNP259.90+1.29 (+0.50%) ▲|UPS105.55-0.28 (-0.26%) ▼|USB60.11+0.06 (+0.09%) ▲|V332.07+3.59 (+1.09%) ▲|VZ45.67-1.07 (-2.28%) ▼|WFC84.06-0.07 (-0.08%) ▼|WMT119.24-0.18 (-0.15%) ▼|XOM136.32-3.41 (-2.44%) ▼|AAPL294.65+0.35 (+0.12%) ▲|ABBV235.29+0.53 (+0.22%) ▲|ABT90.62+0.09 (+0.10%) ▲|ACN130.29+3.28 (+2.58%) ▲|ADBE197.57+0.14 (+0.07%) ▲|AMAT576.53-9.36 (-1.60%) ▼|AMD513.45-6.40 (-1.23%) ▼|AMGN352.48+5.47 (+1.57%) ▲|AMT175.71-3.67 (-2.05%) ▼|AMZN235.54+1.43 (+0.61%) ▲|AVGO379.23-0.93 (-0.24%) ▼|AXP341.87+4.09 (+1.21%) ▲|BA219.37+2.66 (+1.23%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG182.88+13.94 (+8.25%) ▲|BLK979.37-35.97 (-3.54%) ▼|BMY55.15-0.39 (-0.69%) ▼|BNY143.76-3.53 (-2.40%) ▼|BRK-B495.50+2.69 (+0.54%) ▲|C144.05-0.93 (-0.64%) ▼|CAT986.09+1.85 (+0.19%) ▲|CL92.01+0.58 (+0.63%) ▲|CMCSA22.64-0.17 (-0.72%) ▼|COF200.08+2.27 (+1.15%) ▲|COP106.76-3.21 (-2.92%) ▼|COST960.39+2.71 (+0.28%) ▲|CRM153.20-0.23 (-0.15%) ▼|CSCO119.21-1.94 (-1.60%) ▼|CVS102.08+0.51 (+0.50%) ▲|CVX171.54-4.44 (-2.52%) ▼|DE604.97+13.03 (+2.20%) ▲|DHR188.38+9.41 (+5.26%) ▲|DIS101.29-2.24 (-2.16%) ▼|DUK126.03+0.98 (+0.78%) ▲|EMR141.03-2.11 (-1.47%) ▼|FDX315.83-1.42 (-0.45%) ▼|GD344.59-5.75 (-1.64%) ▼|GE364.03+7.56 (+2.12%) ▲|GEV1,047.61+12.63 (+1.22%) ▲|GILD125.67+0.62 (+0.49%) ▲|GM79.16+0.21 (+0.27%) ▲|GOOG344.09-1.99 (-0.58%) ▼|GOOGL344.92-1.17 (-0.34%) ▼|GS1,075.17-19.28 (-1.76%) ▼|HD340.59+16.14 (+4.97%) ▲|HON226.97+4.60 (+2.07%) ▲|IBM263.00-1.94 (-0.73%) ▼|INTC130.46-1.83 (-1.38%) ▼|INTU263.87+5.82 (+2.26%) ▲|ISRG402.54-0.64 (-0.16%) ▼|JNJ240.13+1.05 (+0.44%) ▲|JPM333.82-0.32 (-0.10%) ▼|KO80.75+0.44 (+0.54%) ▲|LIN515.95+3.69 (+0.72%) ▲|LLY1,111.82+4.74 (+0.43%) ▲|LMT493.31-10.36 (-2.06%) ▼|LOW220.86+7.32 (+3.43%) ▲|LRCX367.32-4.01 (-1.08%) ▼|MA494.63+6.56 (+1.34%) ▲|MCD274.48+2.82 (+1.04%) ▲|MDLZ61.90+0.84 (+1.37%) ▲|MDT80.37-0.27 (-0.33%) ▼|META557.65-4.55 (-0.81%) ▼|MMM165.83+3.99 (+2.47%) ▲|MO71.80+0.19 (+0.26%) ▲|MRK120.77+1.17 (+0.98%) ▲|MS220.38-5.66 (-2.50%) ▼|MSFT368.27-5.67 (-1.52%) ▼|MU1,027.39-24.38 (-2.32%) ▼|NEE87.28+0.85 (+0.98%) ▲|NFLX72.16-0.67 (-0.91%) ▼|NKE41.84-0.55 (-1.29%) ▼|NOW93.68-2.26 (-2.36%) ▼|NVDA197.58-2.42 (-1.21%) ▼|ORCL156.40-8.77 (-5.31%) ▼|PEP142.19+0.14 (+0.10%) ▲|PFE24.05-0.68 (-2.73%) ▼|PG152.31+1.45 (+0.96%) ▲|PLTR113.65-3.05 (-2.61%) ▼|PM178.10-0.59 (-0.33%) ▼|QCOM194.61-9.52 (-4.66%) ▼|RTX185.47-0.92 (-0.49%) ▼|SBUX104.00+2.95 (+2.92%) ▲|SCHW91.57-1.60 (-1.72%) ▼|SO95.48+0.55 (+0.57%) ▲|SPG220.91+4.17 (+1.92%) ▲|T22.38-0.43 (-1.88%) ▼|TMO490.69+21.34 (+4.55%) ▲|TMUS181.92-2.65 (-1.44%) ▼|TSLA375.74-5.87 (-1.54%) ▼|TXN303.66-0.70 (-0.23%) ▼|UBER74.20+4.53 (+6.50%) ▲|UNH405.93-3.32 (-0.81%) ▼|UNP259.90+1.29 (+0.50%) ▲|UPS105.55-0.28 (-0.26%) ▼|USB60.11+0.06 (+0.09%) ▲|V332.07+3.59 (+1.09%) ▲|VZ45.67-1.07 (-2.28%) ▼|WFC84.06-0.07 (-0.08%) ▼|WMT119.24-0.18 (-0.15%) ▼|XOM136.32-3.41 (-2.44%) ▼|
27.5 C
New York
Wednesday, June 24, 2026

Tag: patients

newssourceFORcompanyinformationcontent1marketreleases

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment

SINGAPORE, Aug. 10, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™...

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment

SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™...

HistoIndex Marks Another Step Forward with FibroSIGHT™ Plus: Introducing AI-based Quantitative Analysis in Fibrosis Assessment

SINGAPORE, Aug. 11, 2025 /PRNewswire/ -- HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™...

Brain Navi Biotechnology’s NaoTrac performs first surgeries in Spain

Brain Navi has officially landed in Spain! TAIPEI, Aug. 11, 2025 /PRNewswire/ -- Such an achievement has been made possible through the first of many...

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges

LOS ANGELES, Aug. 10, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 405 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2025.

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVO

NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 30, 2025.

SRPT DEADLINE ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline...

NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.

IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients...

IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial

Is Plastic Surgery Safe with Medical Conditions? Dr. Thomas Pane Explains in New Video

PALM BEACH GARDENS, Fla., Aug. 9, 2025 /PRNewswire/ -- For patients considering plastic surgery with underlying medical conditions, Dr. Thomas A. Pane, MD, offers...

Dr. Thomas Pane Answers a Common Question: Do I Need a Tummy Tuck or Just Liposuction?

In a recent video Q&A, board-certified plastic surgeon Dr. Pane breaks down the differences between tummy tuck, revision surgery, and liposuction, helping patients choose...

Dr. Thomas Pane Offers Advanced Breast Implant Revision and Removal Procedures in North Palm Beach, FL

As more women seek revision or removal of breast implants, Dr. Pane offers safe, personalized solutions with long-term, natural-looking results. NORTH PALM BEACH, Fla., Aug....

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. – UNCY

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Wisconsin Recognizes Autonomy of Advanced Practice Registered Nurses, Including CRNAs, with New State Law

ROSEMONT, Ill., Aug. 8, 2025 /PRNewswire/ -- (AANA) -- Wisconsin recently enacted legislation that allows more autonomy for Advanced Practice Registered Nurses (APRNs), including...

Cape Cod Healthcare Advanced Practice Providers File for NLRB Election After Seeking Union Recognition to Strengthen Voice in Patient Care and Working Conditions

Nurse Practitioners, Physician Assistants, and Certified Nurse Midwives at Cape Cod Healthcare move to join the MNA for an equal voice in clinical decisions CAPE...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatients

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers